PDB-code
Browse PDE entries (page 37 of 41)
First 33 34 35 PreviousLast40 39 Next| # | Species | PDE Type | PDB | Chain | Alternate Model | Ligand | Details | File |
|---|---|---|---|---|---|---|---|---|
 | Human | PDE6-5-Chimera | 3jab | C |  | |||
| Human | PDE6-5-Chimera | 3jab | O | | |||
| Human | PDE6-5-Chimera | 3jbq | B | | |||
| Human | PDE6-5-Chimera | 3jbq | F | | |||
| Human | PDE6-5-Chimera | 3jwq | A | 5-{2-ETHOXY-5-[(4-METHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-1-METHYL-3-PROPYL-1H,6H,7H-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE | | ||
| Human | PDE6-5-Chimera | 3jwq | B | 5-{2-ETHOXY-5-[(4-METHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-1-METHYL-3-PROPYL-1H,6H,7H-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE | | ||
| Human | PDE6-5-Chimera | 3jwq | C | 5-{2-ETHOXY-5-[(4-METHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-1-METHYL-3-PROPYL-1H,6H,7H-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE | | ||
| Human | PDE6-5-Chimera | 3jwq | D | 5-{2-ETHOXY-5-[(4-METHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-1-METHYL-3-PROPYL-1H,6H,7H-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE | | ||
| Human | PDE6-5-Chimera | 3jwr | A | | |||
| Human | PDE6-5-Chimera | 3jwr | B | | |||
| Human | PDE6A | 7jsn | A | A | 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE | | |
| Human | PDE6A | 7jsn | A | B | 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE | | |
| Human | PDE6A | 7jsn | B | A | 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE | | |
| Human | PDE6A | 7jsn | B | B | 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE | | |
| Human | PDE7A | 1zkl | A | 3-ISOBUTYL-1-METHYLXANTHINE | | ||
| Human | PDE7A | 3g3n | A | 3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one | | ||
| Human | PDE7A | 4pm0 | A | 2-(cyclopentylamino)-3-ethyl-7-ethynylthieno[3,2-d]pyrimidin-4(3H)-one | | ||
| Human | PDE7A | 4y2b | A | 3-ethyl-2-(propan-2-ylamino)-7-(pyridin-3-yl)thieno[3,2-d]pyrimidin-4(3H)-one | | ||
| Human | PDE8A | 3ecm | A | | |||
| Human | PDE8A | 3ecn | A | 3-ISOBUTYL-1-METHYLXANTHINE | | ||
| Human | PDE8A | 3ecn | B | 3-ISOBUTYL-1-METHYLXANTHINE | | ||
| Human | PDE9A | 2hd1 | A | 3-ISOBUTYL-1-METHYLXANTHINE | | ||
| Human | PDE9A | 2hd1 | B | 3-ISOBUTYL-1-METHYLXANTHINE | | ||
| Human | PDE9A | 2yy2 | A | 3-ISOBUTYL-1-METHYLXANTHINE | | ||
| Human | PDE9A | 2yy2 | B | 3-ISOBUTYL-1-METHYLXANTHINE | | ||
| Human | PDE9A | 3dy8 | A | GUANOSINE-5'-MONOPHOSPHATE | | ||
| Human | PDE9A | 3dy8 | B | 3-ISOBUTYL-1-METHYLXANTHINE | | ||
| Human | PDE9A | 3dyl | A | CYCLICGUANOSINEMONOPHOSPHATE | | ||
| Human | PDE9A | 3dyl | B | 3-ISOBUTYL-1-METHYLXANTHINE | | ||
| Human | PDE9A | 3dyn | A | A | CYCLICGUANOSINEMONOPHOSPHATE | |
This research was performed as part of the "Phosphodiesterase inhibitors for neglected parasitic diseases" (PDE4NPD) programme, which is supported by the European Union 7th Framework Program (FP7/2007-2013) under grant agreement n° 602666.
